The SelectMDx (MDxHealth, Irvine, CA, USA) assay measures the mRNA levels of two genes, HOXC6 and DLX1, that are known to be overexpressed in aggressive prostate cancer [18] (Table 1, Figure 1). The gene discussed is DLX1; the disease is prostate carcinoma.